| scholarly article | Q13442814 |
| P50 | author | Mark Olfson | Q91346889 |
| P2093 | author name string | Ramin Mojtabai | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychiatry | Q7867 |
| P304 | page(s) | 26-36 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | National trends in psychotropic medication polypharmacy in office-based psychiatry | |
| P478 | volume | 67 |
| Q34928129 | "Psychiatry is not a science like others" - a focus group study on psychotropic prescribing in primary care |
| Q44497633 | A comparison of psychotropic medication prescribing patterns in East of England prisons and the general population |
| Q50750295 | A framework to avoid irrational polypharmacy in psychiatry. |
| Q50546631 | A point prevalence study of the use of psychotropic medication in an acute general hospital. |
| Q33560188 | A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies |
| Q39221307 | A quantum chemical study of HOCl-induced transformations of carbamazepine |
| Q47805452 | Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research? |
| Q51606438 | Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008. |
| Q54182516 | Advancing the Quality of Pediatric Antipsychotic Use: Maybe It Takes a PAL. |
| Q90273875 | Adverse event reports in patients taking psychiatric medication during pregnancy from spontaneous reports in Japan and the United States: an approach using latent class analysis |
| Q28686885 | Agomelatine in unipolar depression in clinical practice: a retrospective chart review |
| Q38153098 | Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram |
| Q38139879 | Antidepressant combinations: cutting edge psychopharmacology or passing fad? |
| Q34433880 | Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity |
| Q43795259 | Antidepressant use among survivors of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program |
| Q46898443 | Antidepressant use and method of suicide in the United States: variation by age and sex, 1998-2007. |
| Q41682303 | Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital |
| Q50709810 | Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison. |
| Q34269517 | Antipsychotic polypharmacy in a regional health service: a population-based study. |
| Q44897335 | Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China |
| Q35175610 | Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior |
| Q33560808 | Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points |
| Q37895644 | Antipsychotic utilisation and polypharmacy in Italian residential facilities: a survey |
| Q90265326 | Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination Survey |
| Q40400512 | Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD. |
| Q37626797 | Changes in physician antipsychotic prescribing preferences, 2002-2007. |
| Q48321579 | Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy. |
| Q47946228 | Childhood predictors of antipsychotic use among young people in Finland |
| Q36588320 | Choosing Wisely? Let's Start with Working Wisely. |
| Q55037377 | Clinical correlates of augmentation/combination treatment strategies in major depressive disorder. |
| Q36895976 | Collaborative care for depression in primary care: how psychiatry could "troubleshoot" current treatments and practices |
| Q61806933 | Comorbidity of developmental trauma disorder (DTD) and post-traumatic stress disorder: findings from the DTD field trial |
| Q50718741 | Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatients. |
| Q38950803 | Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009). |
| Q92098351 | Core Patient-Reported Outcomes (PROs) and PRO Measures (PROMs) for Polypharmacy Medicines Reviews: A Sequential Mixed-Methods Study |
| Q90399184 | Correlates of Psychotropic Polypharmacy in outpatient psychiatric clinics of two military tertiary hospitals in Saudi Arabia |
| Q38905891 | Decrease in Statewide Antipsychotic Prescribing after Implementation of Child and Adolescent Psychiatry Consultation Services |
| Q47656425 | Deep pharma: psychiatry, anthropology, and pharmaceutical detox |
| Q57485749 | Demystifying serotonin syndrome (or ) |
| Q34082135 | Differences between patients' and clinicians' report of sleep disturbance: a field study in mental health care in Norway |
| Q36464783 | Difficult encounters with psychiatric patients: a South Texas Psychiatry practice-based research network (PBRN) study |
| Q30878126 | Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data |
| Q43443984 | Economic factors in of patients' nonadherence to antidepressant treatment |
| Q48372273 | Effect of age on the profile of psychotropic users: results from the 2010 National Ambulatory Medical Care Survey |
| Q44980002 | Effectiveness of abbreviated CBT for insomnia in psychiatric outpatients: sleep and depression outcomes |
| Q47865590 | Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial |
| Q38834718 | Effects of depression screening on diagnosing and treating mood disorders among older adults in office-based primary care outpatient settings: An instrumental variable analysis |
| Q48484923 | Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment |
| Q38780621 | Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence. |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q38801507 | Emergency department visits involving benzodiazepines and non-benzodiazepine receptor agonists |
| Q100766031 | Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study |
| Q34002440 | Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support software |
| Q48249859 | Evaluation of the potential for a pharmacokinetic drug-drug interaction between armodafinil and ziprasidone in healthy adults |
| Q47222980 | Factors influencing weight gain in an Asian population of psychiatric inpatients: a retrospective study in Taiwan |
| Q31127895 | Frequency and clinical relevance of potential cytochrome P450 drug interactions in a psychiatric patient population - an analysis based on German insurance claims data. |
| Q48453000 | Frontal lobe function and social adjustment in patients with schizophrenia: near-infrared spectroscopy |
| Q38766834 | Gender differences and psychotropic polypharmacy in psychiatric patients in Brazil: a cross-sectional analysis of the PESSOAS Project |
| Q27022958 | Going beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: a critical review |
| Q38138638 | History, background, concepts and current use of comedication and polypharmacy in psychiatry. |
| Q40497196 | Incident users of antipsychotics: who are they and how do they fare? |
| Q48831169 | Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program |
| Q36026608 | Increasing frequency and fatality of poison control center reported exposures involving medication and multiple substances: data from reports of the American Association of Poison Control Centers 1984-2013. |
| Q37335029 | Independent review of social and population variation in mental health could improve diagnosis in DSM revisions. |
| Q34272241 | Indian Psychiatric Society multicentric study: Prescription patterns of psychotropics in India |
| Q37593865 | Influence of urban residence on use of psychotropic medications in Pennsylvania, USA: cross-sectional comparison of older adults attending senior centers |
| Q58543477 | Initiation of new psychotropic prescriptions without a psychiatric diagnosis among US adults: Rates, correlates, and national trends from 2006 to 2015 |
| Q38045914 | Issues and controversies surrounding the diagnosis and treatment of social anxiety disorder |
| Q35822006 | Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines. |
| Q64078164 | Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines |
| Q35657944 | Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients |
| Q36091252 | Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review |
| Q37671101 | Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission |
| Q35875587 | Mental Health Care Delivered to Younger and Older Adults by Office-Based Physicians Nationally |
| Q37947095 | Metabolic and cardiovascular adverse effects associated with antipsychotic drugs |
| Q36896252 | Multi-modality: a new approach for the treatment of major depressive disorder |
| Q34187891 | National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007 |
| Q44307834 | National trends (2003-2009) and factors related to psychotropic medication use in community-dwelling elderly population |
| Q38110358 | On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal |
| Q30630496 | Optogenetics in psychiatric animal models |
| Q50804521 | Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy. |
| Q38800074 | Pattern of psychotropic medication use over two decades in Australian women |
| Q33982992 | Patterns of psychotropic medication prescriptions by psychiatrists for private clinic outpatients in kerman province, iran |
| Q39487718 | Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing. |
| Q37115466 | Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service |
| Q38143335 | Polypharmacy and bipolar disorder: what's personality got to do with it? |
| Q38060181 | Polypharmacy and food-drug interactions among older persons: a review |
| Q60438395 | Polypharmacy in Attention Deficit Hyperactivity Disorder Treatment: Current Status, Challenges and Next Steps |
| Q36841579 | Polypharmacy in psychiatry: a review |
| Q38214474 | Polypharmacy in the treatment of subjects with intellectual disability |
| Q35548200 | Polypharmacy or medication washout: an old tool revisited |
| Q40610885 | Potential drug-drug interaction in Mexican patients with schizophrenia |
| Q38668808 | Potentially Inappropriate Antidepressant Prescriptions Among Older Adults in Office-Based Outpatient Settings: National Trends from 2002 to 2012. |
| Q90264515 | Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders |
| Q90109696 | Predictors of 30-day rehospitalization in a sample of hospitalized patients with Bipolar I disorder |
| Q37011220 | Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. |
| Q50072228 | Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore. |
| Q64943898 | Prevalence of Psychotropic Polypharmacy and Associated Healthcare Resource Utilization during Initial Phase of Care among Adults with Cancer in USA. |
| Q38714484 | Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland |
| Q35029088 | Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy |
| Q57309250 | Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development |
| Q36198525 | Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine. |
| Q44758533 | Psychotropic drug and polypharmacy use among adolescents and young adults: findings from the Finnish 1981 Nationwide Birth Cohort Study |
| Q44379875 | Psychotropic medication discussions in older adults' primary care office visits: So much to do, so little time |
| Q50632717 | Psychotropic medication in geriatric psychiatric patients: use and unreported use in relation to serum concentrations. |
| Q46186178 | Psychotropic medication patterns among youth in juvenile justice |
| Q38687957 | Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study. |
| Q90030941 | Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders |
| Q33818732 | Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis |
| Q38687222 | Risk Factors for Tremor in a Population of Patients with Severe Mental Illness: An 18-year Prospective Study in a Geographically Representative Sample (The Curacao Extrapyramidal Syndromes Study XI). |
| Q38536939 | Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis |
| Q37568887 | Shooting the Messenger: The Case of ADHD. |
| Q33971229 | Socioeconomic status and prescribing for schizophrenia: analysis of 3200 cases from the Glasgow Psychosis Clinical Information System (PsyCIS) |
| Q33749002 | Suicide and unintentional poisoning mortality trends in the United States, 1987-2006: two unrelated phenomena? |
| Q40572847 | Suicide risk linked with clinical consultation frequency, psychiatric diagnoses and psychotropic medication prescribing in a national study of primary-care patients |
| Q54515937 | The Impact of Psychotropic Drug Costs on the Brazilian Family Budget: An Analysis of the Family Budget Surveys of 2003 and 2009. |
| Q33836863 | The mistreatment of major depressive disorder |
| Q36442729 | The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled children |
| Q38027452 | The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective |
| Q35123728 | The utilisation of Complementary and Alternative Medicine (CAM) among ethnic minorities in South Korea |
| Q37546344 | Time Trend in Psychotropic Medication Use in Spain: A Nationwide Population-Based Study |
| Q40631721 | Treatment patterns in inpatient depression care. |
| Q39006064 | Treatment profiles in a Danish psychiatric university hospital department |
| Q38925657 | Trends in antipsychotic prescriptions for Japanese outpatients during 2006-2012: a descriptive epidemiological study |
| Q34506756 | Trends in prescribing of sedative-hypnotic medications in the USA: 1993-2010. |
| Q44842205 | Trends in psychotropic use in Saskatchewan from 1983 to 2007. |
| Q46814329 | Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. |
| Q39412323 | Unintentional alcohol and drug poisoning in association with substance use disorders and mood and anxiety disorders: results from the 2010 Nationwide Inpatient Sample |
| Q48067714 | Universal cures for idiosyncratic illnesses: A genealogy of therapeutic reasoning in the mental health field |
| Q47152270 | Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome |
| Q47584841 | Use of Photovoice to Understand the Experience of Taking Psychotropic Medications |
| Q33699936 | Use of Psychotropic Medications among Youth in Treatment Foster Care |
| Q47390596 | Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001-2009). |
| Q58549671 | What causes medication administration errors in a mental health hospital? A qualitative study with nursing staff |
| Q38155978 | Why is psychiatry prone to fads? |
| Q43550125 | [Factors associated with high exposure to psychotropic drugs in a Montreal catchment epidemiological area]. |
| Q57485688 | Démystifier le syndrome (ou la toxicité) sérotoninergique |
Search more.